Synerzys Novaceuticals Private Limited
Manufactures basic chemicals, incorporated in 2015, based in Telangana.
2015 | Medak, Telangana (India) | Active
Synerzys Novaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -57.13%
- Ebitda -18.43%
- Net Worth -53.41%
- Total Assets 20.83%
About Synerzys Novaceuticals
Synerzys Novaceuticals Private Limited (SNPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2015 (Nine years and nine months 18 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kandhagatla Rajnarayana, Kaushal Shah, and Nazneen Hamid serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100TG2015PTC098988
- Company No.
098988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals and Materials
Who are the key members and board of directors at Synerzys Novaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushal Shah  | Director | 20-May-2015 | Current |
| Kandhagatla Rajnarayana | Director | 20-May-2015 | Current |
| Nazneen Hamid | Director | 20-May-2015 | Current |
Financial Performance of Synerzys Novaceuticals.
Synerzys Novaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 57.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 53.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synerzys Novaceuticals?
In 2021, Synerzys Novaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anwita Drugs & Chemicals Private LimitedKandhagatla Rajnarayana is a mutual person
Techinvention Lifecare Private LimitedNazneen Hamid is a mutual person
- Acesynerzys Pharmalinks Llp
Kaushal Shah is a mutual person
- Synerzys Lifecare Private Limited
Kaushal Shah is a mutual person
- Synergy Pharmasource Private Limited
Nazneen Hamid is a mutual person
- Virchowtech Vaccines & Biologics Private Limited
Nazneen Hamid is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synerzys Novaceuticals?
Unlock and access historical data on people associated with Synerzys Novaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synerzys Novaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synerzys Novaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Synerzys Novaceuticals
Recent activity within the organization
- Annual General Meeting
Synerzys Novaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Synerzys Novaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Kandhagatla Rajnarayana was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 9 years 9 months .
- Director Appointment
Kaushal Kirtikumar Shah was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 9 years 9 months .
- Director Appointment
Nazneen Hamid was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 9 years 9 months .
- Company Incorporation
Synerzys Novaceuticals Private Limited was registered on 20 May 2015 with Roc Hyderabad & aged 9 years 9 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Synerzys Novaceuticals Private Limited?
Synerzys Novaceuticals Private Limited was incorporated on 20 May 2015.
What is authorized share capital and paid-up capital of Synerzys Novaceuticals Private Limited?
The authorized share capital of Synerzys Novaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Synerzys Novaceuticals Private Limited?
Currently 3 directors are associated with Synerzys Novaceuticals Private Limited.
- Kandhagatla Rajnarayana
- Kaushal Kirtikumar Shah
- Nazneen Hamid
What is the registered address of Synerzys Novaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Synerzys Novaceuticals Private Limited is Plot No.25, Gowthamnagar India, Patancheru, Telangana, 502319.
What is the corporate identification number (CIN) and company number of Synerzys Novaceuticals Private Limited?
The corporate identification number (CIN) of Synerzys Novaceuticals Private Limited is U24100TG2015PTC098988 and the company number is 098988 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Synerzys Novaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Synerzys Novaceuticals Private Limited has experienced an downturn of -53.41%.
When was the last Balance Sheet of Synerzys Novaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Synerzys Novaceuticals Private Limited was filed with the ROC on 31 Mar 2024.